BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Oncology News, Insights, Stories by OncoDaily
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260226
DTEND;VALUE=DATE:20260301
DTSTAMP:20260406T035543
CREATED:20251022T222055Z
LAST-MODIFIED:20251022T222108Z
UID:10000286-1772064000-1772323199@oncodaily.com
SUMMARY:2026 ASCO GU Cancers Symposium
DESCRIPTION:The 2026 ASCO Genitourinary (GU) Cancers Symposium is scheduled to take place from February 26 to 28\, 2026\, at Moscone West in San Francisco\, California. \nThis premier event\, hosted by the American Society of Clinical Oncology (ASCO)\, will focus on the latest advancements in the prevention\, diagnosis\, and treatment of genitourinary cancers\, including prostate\, bladder\, kidney\, and testicular cancers. The symposium will feature groundbreaking research presentations\, expert-led educational sessions\, and in-depth discussions on key topics in GU oncology. \nAttendees can expect a rich program that combines plenary lectures\, oral abstract presentations\, poster sessions\, and interactive workshops. The event emphasizes multidisciplinary collaboration\, bringing together medical oncologists\, urologists\, radiation oncologists\, pathologists\, advanced practice providers\, nurses\, and patient advocates to discuss best practices and evolving treatment paradigms. Special focus sessions will cover precision oncology\, immunotherapy\, novel targeted therapies\, survivorship\, and health equity in GU cancers\, highlighting both scientific innovation and patient-centered care. \nThe symposium also offers networking opportunities with leading global experts\, enabling participants to exchange knowledge\, discuss challenges\, and foster collaborations that advance GU oncology. Both in-person and virtual attendance options are available\, allowing wider access for international participants. \nRegistration. \nYou can find more posts featuring ASCO on OncoDaily.
URL:https://oncodaily.com/event/asco-396360
LOCATION:Moscone West\, 800 Howard Street\, San Francisco\, United States
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/10/GU26.png
ORGANIZER;CN="American Society of Clinical Oncology":MAILTO:https://asco.org/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260226T090000
DTEND;TZID=America/Halifax:20260226T170000
DTSTAMP:20260406T035543
CREATED:20251123T182557Z
LAST-MODIFIED:20251123T182645Z
UID:10000391-1772096400-1772125200@oncodaily.com
SUMMARY:2026 Translating Evidence to Action: Elevating Cancer Care
DESCRIPTION:The “2026 Translating Evidence to Action: Elevating Cancer Care“ is an annual continuing medical education (CME) forum organized by Memorial Sloan Kettering Cancer Center (MSK)\, scheduled as a live virtual conference on Thursday\, February 26\, 2026. \nThis program is designed for healthcare professionals across all disciplines to explore how evidence-based research can be translated into meaningful quality improvements in clinical practice and patient outcomes. The conference features exemplary quality improvement projects\, practice-based initiatives\, two dynamic Rapid-Fire Poster Sessions\, and a keynote address on “Technology with a Human Pulse: Advancing Patient Care with Innovation and Intention.” Participants can earn up to 6.50 AMA PRA Category 1 Credits. \nRegister.
URL:https://oncodaily.com/event/translating-evidence-to-action-415021
LOCATION:
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/11/MSK.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260227
DTEND;VALUE=DATE:20260301
DTSTAMP:20260406T035543
CREATED:20251213T232554Z
LAST-MODIFIED:20251213T232608Z
UID:10000486-1772150400-1772323199@oncodaily.com
SUMMARY:Updates on Advanced Breast Cancer: Local Management and Other New Perspectives
DESCRIPTION:The Updates on Advanced Breast Cancer: Local Management and Other New Perspectives conference is a one-and-a-half-day\, in-person event scheduled for February 27–28\, 2026\, at the Houston Marriott Medical Center in Houston\, TX. \nHosted by The University of Texas MD Anderson Cancer Center\, the activity’s main goal is to emphasize the integration of novel therapies and diagnostic tools into clinical practice\, focusing on areas like liquid biopsy\, ctDNA\, and MRD monitoring for inflammatory breast cancer (IBC). \nRegister.
URL:https://oncodaily.com/event/advanced-breast-cancer-427773
LOCATION:Houston Marriott Medical Center/Museum District\, 6580 Fannin Street\, Driveway Entrance on\, 1730 Dryden Rd\, Houston\, TX\, 77030\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/breast-cancer.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260227T080000
DTEND;TZID=America/Halifax:20260227T170000
DTSTAMP:20260406T035543
CREATED:20260227T104948Z
LAST-MODIFIED:20260227T104948Z
UID:10000673-1772179200-1772211600@oncodaily.com
SUMMARY:5th Annual International Congress on Pediatric Oncology 2026
DESCRIPTION:The 5th Annual International Congress on Pediatric Oncology will be held virtually on November 6\, 2026. \nChaired by Dr. Jacqueline M. Kraveka of the Medical University of South Carolina\, this congress focuses on the rapid evolution of pediatric solid and hematologic malignancies. The program highlights clinical trial interpretations regarding novel targeted agents and immunotherapies\, alongside new techniques for molecular tumor characterization to improve outcomes for pediatric and adolescent/young adult (AYA) patients. Key highlights include focused sessions on navigating challenges in relapsed/refractory neuroblastoma\, the integration of CAR-T cell therapies\, and innovative strategies for managing late effects of treatment in survivorship care. \nRegister now.
URL:https://oncodaily.com/event/pediatric-oncology-462051
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/02/BeFunky-collage-2026-02-27T145029.279.webp
ORGANIZER;CN="Physicians' Education Resource":MAILTO:onc-info@gotoper.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260227T090000
DTEND;TZID=America/New_York:20260227T100000
DTSTAMP:20260406T035543
CREATED:20260124T235207Z
LAST-MODIFIED:20260124T235227Z
UID:10000620-1772182800-1772186400@oncodaily.com
SUMMARY:Outcomes of Adolescent and Young Adult Patients with AML Treated on Adult Versus Pediatric Protocols - Resonance
DESCRIPTION:The ALRCaN Global webinar\, titled “Outcomes of adolescent and young adult patients with AML treated on adult versus pediatric protocols\,” is scheduled for Friday\, February 27\, 2026\, at 09:00 AM ET. \nFeaturing Dr. Ira Kraft\, the session will explore the comparative therapeutic outcomes for Adolescent and Young Adult (AYA) patients with Acute Myeloid Leukemia (AML) based on the clinical protocol used. Organized by Resonance Health and created by Ivana Cáceres\, the event is supported by the leadership team of Scott Howard\, Stacy Cooper\, Archie Bleyer\, and Dan Douer. This discussion provides a vital platform for the global medical community to evaluate the nuances between adult and pediatric treatment frameworks and their specific impact on the AYA population.
URL:https://oncodaily.com/event/aml-446544
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/Ira-Kraft.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260301
DTEND;VALUE=DATE:20260304
DTSTAMP:20260406T035543
CREATED:20251222T220754Z
LAST-MODIFIED:20251222T220803Z
UID:10000522-1772323200-1772582399@oncodaily.com
SUMMARY:Lung Cancer Voices Summit 2026
DESCRIPTION:The Lung Cancer Voices Summit\, organized by GO2 for Lung Cancer\, is a premier advocacy event scheduled for March 1–3\, 2026\, in Washington\, D.C. As the largest annual meeting of its kind\, it unites patients\, caregivers\, and medical professionals for a comprehensive program of education and direct advocacy on Capitol Hill. \nThe summit empowers participants to share their personal stories with federal lawmakers to champion increased research funding and policies that ensure affordable\, high-quality healthcare for the lung cancer community. \nRegister.
URL:https://oncodaily.com/event/lung-cancer-voices-432821
LOCATION:Hilton Washington DC Capitol Hill\, 525 New Jersey Ave NW\, Washington\, D.C.\, DC\, 20001\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/Lung-Cancer-Voices.webp
ORGANIZER;CN="GO2 for Lung Cancer":MAILTO:support@go2.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260301T170000
DTEND;TZID=America/Halifax:20260303T210000
DTSTAMP:20260406T035543
CREATED:20251006T105343Z
LAST-MODIFIED:20251011T202612Z
UID:10000269-1772384400-1772571600@oncodaily.com
SUMMARY:Call-on Congress by Fight Colorectal Cancer
DESCRIPTION:Now in its 20th year\, Call-on Congress is Fight Colorectal Cancer’s (Fight CRC) signature advocacy event – founded on Nancy Roach’s belief that patients must have a seat at the policy table. Each year\, patients\, survivors\, caregivers\, and healthcare professionals gather in Washington\, D.C. to meet with lawmakers\, share their stories\, and drive policy change. \nRegistration Includes: \n\nFight CRC swag bag\nVirtual and in-person advocacy training\nExclusive advocacy resources\nScheduled congressional meetings\nMeals (Mon: breakfast and lunch | Tue: breakfast and dinner)\n\nPreparation Tips: \n\nReview training materials and key talking points in advance\nJoin the Community of Champions for updates\, hotel info\, and volunteer opportunities\nWear blue! Casual for training\, business casual for Capitol Hill\, and comfortable shoes\n\nHotel and Scholarships: \nDiscounted hotel rooms are available for $185/night. \nScholarships are offered to make attendance accessible: \n\nAdvocate Travel Scholarship for adults\nJunior Advocate Leadership Scholarship for youth (ages 13–18) and a parent/guardian.\n\nYou can find more posts featuring Fight Colorectal Cancer.
URL:https://oncodaily.com/event/call-on-congress-385939
LOCATION:Hilton Arlington National Landing\, 2399 Richmond Highway Arlington\, VA 22202 United States\, Arlington\, VA\, 22202\, United States
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/10/Image-10-1.jpeg
ORGANIZER;CN="Fight Colorectal Cancer":MAILTO:info@fightcrc.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260303
DTEND;VALUE=DATE:20260305
DTSTAMP:20260406T035543
CREATED:20251224T110255Z
LAST-MODIFIED:20251224T110307Z
UID:10000525-1772496000-1772668799@oncodaily.com
SUMMARY:The Prevent Breast Cancer Research Conference
DESCRIPTION:The Prevent Breast Cancer Research Conference 2026 is a two-day scientific symposium focused on the clinical and translational aspects of breast cancer risk assessment\, early detection\, and prevention strategies. Scheduled for March 3–4\, 2026\, in Manchester\, the event features technical presentations on genomic risk prediction\, hormonal signaling\, and health inequalities in screening. \nThe program is structured for clinicians and researchers\, incorporating a £10\,000 “Dragons’ Den” research grant competition and a peer-reviewed poster session to highlight emerging data in the field of preventative oncology.
URL:https://oncodaily.com/event/prevent-breast-cancer-433299
LOCATION:Treehouse Hotel Manchester\, Blackfriars St\, Manchester\, Manchester\, Greater Manchester\, M3 2EQ\, United Kingdom
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/Screenshot-2025-12-24-150223.webp
ORGANIZER;CN="Prevent Breast Cancer":MAILTO:info@preventbreastcancer.org.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260304
DTEND;VALUE=DATE:20260305
DTSTAMP:20260406T035543
CREATED:20251227T145828Z
LAST-MODIFIED:20251227T145837Z
UID:10000538-1772582400-1772668799@oncodaily.com
SUMMARY:ESMO Deep Dive: Genitourinary Cancers : Beyond Cure: Optimizing Medical Care in Metastatic Bladder Cancer 2026
DESCRIPTION:The ESMO Deep Dive: Genitourinary Cancers: Beyond Cure: Optimizing Medical Care in Metastatic Bladder Cancer 2026 is a specialized scientific webinar designed to provide an in-depth clinical analysis of the treatment landscape for metastatic urothelial carcinoma (mUC). \nScheduled for March 4\, 2026\, this virtual session focuses on the technical challenges of managing advanced disease where cure is no longer the primary objective\, emphasizing the optimization of medical care through personalized treatment sequencing. This educational event\, chaired by Michiel S. van der Heijden\, is part of the ESMO Deep Dive series\, which utilizes evidence-based data and expert-led discussion to refine clinical decision-making for complex genitourinary oncological cases. \nRegister.
URL:https://oncodaily.com/event/esmo-deep-dive-434709
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMO-Deep-Dive.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260304
DTEND;VALUE=DATE:20260306
DTSTAMP:20260406T035543
CREATED:20251126T003017Z
LAST-MODIFIED:20251126T003058Z
UID:10000405-1772582400-1772755199@oncodaily.com
SUMMARY:ESMO Advanced Course on Precision Medicine for Patients with HR+ HER2- Advanced Breast Cancer: Testing\, Selecting\, Treating 2026: Zurich
DESCRIPTION:The ESMO Advanced Course on Precision Medicine for Patients with HR+ HER2- Advanced Breast Cancer: Testing\, Selecting\, Treating 2026: Zurich is a two-day course for experienced oncologists and specialists\, focusing on using precision medicine to manage patients with HR-positive\, HER2-negative metastatic breast cancer. \nThe event is scheduled to take place on March 4–5\, 2026\, in Zurich\, Switzerland. \nThe application deadline for participation is January 7\, 2026\, at 23:59 CET. The course objectives include understanding the rationale and technical background of biomarker testing\, using results for optimal patient selection\, and discussing the proactive management of precision-medicine-based treatments. \nApply.
URL:https://oncodaily.com/event/breast-cancer-416477
LOCATION:Zurich\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/esmo-2-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260305
DTEND;VALUE=DATE:20260307
DTSTAMP:20260406T035543
CREATED:20260221T100152Z
LAST-MODIFIED:20260221T100152Z
UID:10000659-1772668800-1772841599@oncodaily.com
SUMMARY:International Conference on Oncology\, Cardiology and Critical Care Strategies (ICOCCS 2026)
DESCRIPTION:The Institute for Global Academic Excellence (IGAE) is set to host the International Conference on Oncology\, Cardiology and Critical Care Strategies (ICOCCS-26) from March 5–6\, 2026\, in Manchester\, UK. \nOperating in a hybrid mode to facilitate global participation\, this multidisciplinary summit serves as a prestigious platform for scholars and healthcare professionals to converge on the intersections of three vital medical fields. The 2026 program is specifically designed to drive interdisciplinary collaboration\, showcasing groundbreaking research and emerging technological methodologies that address complex clinical challenges. By fostering a high-level dialogue between academia and industry\, ICOCCS-26 aims to accelerate the translation of innovative strategies into global practice while providing a robust platform for research publication in indexed journals. \nRegister.
URL:https://oncodaily.com/event/icoccs-2026-458957
LOCATION:TX
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/02/Annotation-2026-02-21-140142-1.webp
ORGANIZER;CN="Institute for Global Academic Excellence (IGAE)":MAILTO:support@igaeglobal.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260305
DTEND;VALUE=DATE:20260309
DTSTAMP:20260406T035543
CREATED:20260225T073206Z
LAST-MODIFIED:20260225T075429Z
UID:10000666-1772668800-1773014399@oncodaily.com
SUMMARY:43rd Annual Miami Breast Cancer Conference
DESCRIPTION:The 43rd Annual Miami Breast Cancer Conference will take place from March 5–8\, 2026\, at the Fontainebleau Miami Beach. \nLed by Program Chair Dr. Patrick I. Borgen alongside co-chairs Dr. Reshma Jagsi and Dr. Hope S. Rugo\, this premier multidisciplinary event gathers surgical\, medical\, and radiation oncologists to bridge the gap between emerging clinical data and real-world practice. The 2026 program features the signature “Medical Crossfire” interactive debates\, specialized tumor boards\, and deep dives into high-impact topics such as antibody-drug conjugates (ADCs)\, HER2-low classification\, and the integration of AI in breast imaging. Designed for immediate clinical application\, the conference remains the essential forum for breast cancer professionals to optimize patient-centered care and therapeutic sequencing in an rapidly evolving landscape. \nRegister now.
URL:https://oncodaily.com/event/breast-cancer-460381
LOCATION:Fontainebleau Miami Beach\, 4441 Collins Avenue\, Miami Beach\, Florida\, 33140\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/02/BeFunky-collage-2026-02-25T113152.496.webp
ORGANIZER;CN="Physicians' Education Resource":MAILTO:onc-info@gotoper.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260305T130000
DTEND;TZID=America/Halifax:20260305T140000
DTSTAMP:20260406T035543
CREATED:20251111T175024Z
LAST-MODIFIED:20251111T175037Z
UID:10000340-1772715600-1772719200@oncodaily.com
SUMMARY:Provider Education Series - Lung Health Foundation
DESCRIPTION:The Lung Health Foundation is offering a free\, accredited virtual “Lunch and Learn” series – the Provider Education Series – consisting of three one-hour sessions designed to deliver high-impact\, evidence-based education to healthcare professionals. \nThese sessions will provide practical insights from expert speakers on the diagnosis\, treatment\, and management of lung diseases\, with a focus on severe asthma\, COPD\, and lung cancer. Participants will enhance their clinical knowledge\, receive updates on current lung cancer risk assessment and screening guidelines\, and earn valuable CPD credits to support best practices. \n\nSession 1: September 18\, 2025: What You Need to Know – Managing Severe Asthma in Your Practice\nSession 2: November 27th\, 2025: What You Need to Know – Optimizing COPD Treatment and Reducing Exacerbations in Your Practice\nSession 3: March 5th\, 2026: What You Need to Know – Managing Lung Cancer Risk Assessment in Your Practice
URL:https://oncodaily.com/event/provider-education-series-407279
LOCATION:TX
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/11/Provider-Education-Series.jpg
ORGANIZER;CN="Lung Health Foundation":MAILTO:info@lunghealth.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260306
DTEND;VALUE=DATE:20260307
DTSTAMP:20260406T035543
CREATED:20260121T220322Z
LAST-MODIFIED:20260121T220340Z
UID:10000607-1772755200-1772841599@oncodaily.com
SUMMARY:Irish Thoracic Society Spring Meeting 2026
DESCRIPTION:The Irish Thoracic Society Spring Meeting 2026\, organized by the Irish Thoracic Society\, is scheduled to take place on Friday\, March 6\, 2026\, at the Radisson Blu Hotel in Athlone\, Ireland. \nThis one-day scientific gathering serves as a key forum for respiratory healthcare professionals across Ireland to discuss clinical updates and share the latest research in thoracic medicine. Given the event’s high demand and history of selling out quickly\, early registration is encouraged for attendees\, who can also benefit from discounted hotel rates at the venue.
URL:https://oncodaily.com/event/irish-thoracic-society-444822
LOCATION:Radisson Blu Hotel\, Athlone\, Northgate St\, Athlone\, County Westmeath\, N37 A8X9\, Ireland
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ITS.webp
ORGANIZER;CN="Irish Thoracic Society":MAILTO:info@irishthoracicsociety.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260306
DTEND;VALUE=DATE:20260307
DTSTAMP:20260406T035543
CREATED:20260303T103322Z
LAST-MODIFIED:20260303T103322Z
UID:10000684-1772755200-1772841599@oncodaily.com
SUMMARY:56th Annual Radiation Oncology Research Seminar
DESCRIPTION:The 56th Annual Radiation Oncology Research Seminar\, hosted by the University of Florida Department of Radiation Oncology\, will be held on Friday\, March 6\, 2026\, at the Hilton University of Florida Conference Center.  \nThis long-standing event serves as a vital forum for sharing data-driven research and innovative radiotherapy techniques. This year’s seminar features two concurrent programs—the Physician Scientist Session and the Radiation Therapists’ and Oncology RN Seminar. A major highlight is the keynote address by Dr. Robert W. Mutter\, Chair of Research at the Mayo Clinic Comprehensive Cancer Center\, as well as a multidisciplinary panel dedicated to de-intensifying care for early-stage breast cancer. \nRegister now.
URL:https://oncodaily.com/event/radiation-oncology-463767
LOCATION:Hilton University of Florida Conference Center\, 1714 SW 34th Street\, Gainesville\, FL\, 32607\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/03/BeFunky-collage-2026-03-03T143231.222.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260306
DTEND;VALUE=DATE:20260308
DTSTAMP:20260406T035543
CREATED:20251204T111021Z
LAST-MODIFIED:20251204T120723Z
UID:10000441-1772755200-1772927999@oncodaily.com
SUMMARY:APPOS Charlotte 2026: Advanced Practice Providers Oncology Summit
DESCRIPTION:The APPOS Charlotte 2026: Advanced Practice Providers Oncology Summit returns to Charlotte on March 6–7\, 2026\, bringing oncology clinicians together for a focused\, two-day CE program dedicated to the latest advances in cancer care. \nDesigned with and for advanced practice providers\, this summit delivers evidence-based updates\, practical management strategies\, and collaborative learning to strengthen patient care and team communication across the oncology continuum. \nRegister.
URL:https://oncodaily.com/event/appos-charlotte-421252
LOCATION:The Ballantyne Hotel\, Charlotte\, Ballantyne Commons Parkway Charlotte\, Charlotte\, 28277\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/BeFunky-collage-2025-12-04T150913.833.webp
ORGANIZER;CN="Horizon CME":MAILTO:info@horizoncme.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260306
DTEND;VALUE=DATE:20260308
DTSTAMP:20260406T035543
CREATED:20251221T215815Z
LAST-MODIFIED:20251221T215832Z
UID:10000517-1772755200-1772927999@oncodaily.com
SUMMARY:ESMO Advanced Course on Management of Patients with Localised Bladder Cancer: State-of-the-Art Therapeutic Strategies and Ongoing Research 2026: Zurich
DESCRIPTION:The ESMO Advanced Course on Management of Patients with Localised Bladder Cancer: State-of-the-Art Therapeutic Strategies and Ongoing Research 2026: Zurich is an intensive educational program designed to provide medical oncologists with a comprehensive update on state-of-the-art therapeutic strategies and ongoing research. \nScheduled for March 6–7\, 2026\, in Zurich\, Switzerland\, the course focuses on multidisciplinary care\, evidence-based management\, and the interpretation of novel translational research\, including molecular profiling and clinical trials. \nLed by co-chairs Viktor Gruenwald and Bernadett Szabados\, the program offers successful applicants complimentary registration\, accommodation\, and a travel grant\, emphasizing ESMO’s commitment to advancing professional expertise in bladder cancer treatment. \nApplication.
URL:https://oncodaily.com/event/esmo-432406
LOCATION:Zurich\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMO.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260306
DTEND;VALUE=DATE:20260309
DTSTAMP:20260406T035543
CREATED:20251113T220524Z
LAST-MODIFIED:20251113T220546Z
UID:10000349-1772755200-1773014399@oncodaily.com
SUMMARY:Pathology Update 2026
DESCRIPTION:Pathology Update 2026 is the annual scientific conference hosted by The Royal College of Pathologists of Australia (RCPA). It will take place from March 6 to March 8\, 2026\, in Sydney\, NSW. \nThe meeting provides a multi-disciplinary pathology program for pathologists\, scientists\, and trainees\, focusing on new developments and challenges in the field under the theme\, “Many Paths. Shared Focus. Stronger Together.” The event will include plenary sessions\, workshops\, and abstract presentations from both local and international pathology experts\, coinciding with the celebration of the RCPA’s 70th anniversary.
URL:https://oncodaily.com/event/pathology-update-408954
LOCATION:International Convention Centre
Sydney\, Australia\, 14 Darling Dr\, Sydney NSW 2000\, Australia\, Sydney\, NSW\, 2000\, Australia
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/11/575111358_1424538106348656_696976248818726427_n.jpg
ORGANIZER;CN="Royal College of Pathologists of Australia":MAILTO:rcpa@rcpa.edu.au
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260306
DTEND;VALUE=DATE:20260309
DTSTAMP:20260406T035543
CREATED:20260120T093429Z
LAST-MODIFIED:20260120T093436Z
UID:10000597-1772755200-1773014399@oncodaily.com
SUMMARY:Best of the 19th St. Gallen International Breast Cancer Conference - India
DESCRIPTION:The Best of the 19th St. Gallen International Breast Cancer Conference – India\, incorporating the Asian Cancer Consensus Meet\, is a premier scientific event scheduled for March 6-8\, 2026\, in Kolkata\, India. \nOrganized by the Institute of Breast Diseases\, Kolkata\, the conference will be held at Taj Taal Kutir and serves as the official regional update to the global St. Gallen Consensus. The program bridges international clinical standards with regional relevance\, featuring a keynote by Prof. Michael Gnant (Co-Chair of SGBCC\, Vienna) and consensus-building sessions tailored for Low- and Middle-Income Countries (LMICs). \nRegister. \nAbstract Submission.
URL:https://oncodaily.com/event/breast-cancer-443868
LOCATION:Taj Taal Kutir\, Kolkata\, No. 11E/65\, Eco Tourism Park\, Eco Park Rd\, AA II\, Deshbandhu Nagar\, New Town (Kolkata)\, West Bengal\, 700156\, India
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/Screenshot-2026-01-20-133340.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260306T080000
DTEND;TZID=America/Halifax:20260308T121500
DTSTAMP:20260406T035543
CREATED:20251218T151631Z
LAST-MODIFIED:20251218T151759Z
UID:10000511-1772784000-1772972100@oncodaily.com
SUMMARY:26th Multidisciplinary Management of Cancers: A Case-Based Approach
DESCRIPTION:The 26th Multidisciplinary Management of Cancers: A Case-Based Approach\, held March 6–8\, 2026\, at the Meritage Resort and Spa\, will focus on the latest multidisciplinary strategies in clinical oncology. \nThe meeting features tumor board–style case discussions across breast\, gastrointestinal\, genitourinary\, hematologic\, lymphoma\, and thoracic cancers\, led by faculty and expert panels from Stanford\, UC Davis\, UC San Francisco\, and the broader oncology community. \nRegister here.
URL:https://oncodaily.com/event/cancers-430551
LOCATION:The Meritage Resort and Spa\, 875 Bordeaux Way\, Napa\, CA\, 94558\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/BeFunky-collage-92-Picsart-AiImageEnhancer.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260306T090000
DTEND;TZID=America/Halifax:20260306T100000
DTSTAMP:20260406T035543
CREATED:20260306T041816Z
LAST-MODIFIED:20260306T041816Z
UID:10000685-1772787600-1772791200@oncodaily.com
SUMMARY:CART19-BE-02 trial: From Bench to Bedside and Beyond - Resonance
DESCRIPTION:The ALRCaN Global webinar\, titled “CART19-BE-02 trial: From Bench to Bedside and Beyond—Implementing a Hospital-Based CAR T Program and Integrating It into the Spanish NHS\,” is scheduled for Friday\, March 06\, 2026\, at 09:00 AM ET (06:00 PM Armenia Standard Time).  \nFeaturing Dr. Valentín Ortiz-Maldonado\, the session will explore the clinical implementation and integration of Varnimcabtagene autoleucel for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia within the Spanish National Health Service. Organized by Resonance Health\, the event is supported by the leadership team of Scott Howard\, Stacy Cooper\, Archie Bleyer\, and Dan Douer. This discussion provides a vital platform for the global medical community to evaluate the multicentre\, phase 2 trial data and the logistical frameworks required to move advanced CAR T therapies from experimental stages to standardized hospital care.
URL:https://oncodaily.com/event/resonance-465252
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/03/Gemini_Generated_Image_xebl5mxebl5mxebl-1.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260306T130000
DTEND;TZID=America/Halifax:20260307T144500
DTSTAMP:20260406T035543
CREATED:20260114T211734Z
LAST-MODIFIED:20260114T211750Z
UID:10000573-1772802000-1772894700@oncodaily.com
SUMMARY:Australian Precision Oncology Symposium 2026
DESCRIPTION:The Australian Precision Oncology Symposium 2026 (APOS 26) is a two-day scientific event focused on the theme “Mainstreaming Precision Oncology: Transforming Care Through Science\, Medicine and Equity.” \nScheduled for March 6–7\, 2026\, in Sydney\, the symposium serves as a collaborative platform for researchers\, clinicians\, and industry representatives to discuss the integration of genomic medicine into standard cancer care. The program includes technical sessions\, a symposium dinner\, and presentations from a diverse speaking faculty specializing in clinical genomics and molecular oncology. \nRegister.
URL:https://oncodaily.com/event/australian-precision-oncology-441165
LOCATION:John Niland Scientia Building\, G19 Library Rd\, Sydney\, New South Wales\, 2033\, Australia
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/APOS.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260307
DTEND;VALUE=DATE:20260308
DTSTAMP:20260406T035543
CREATED:20251215T190559Z
LAST-MODIFIED:20251215T190612Z
UID:10000498-1772841600-1772927999@oncodaily.com
SUMMARY:OPN Pacific Northwest Chapter Conference 2026
DESCRIPTION:The OPN Pacific Northwest Chapter Conference 2026 is a one-day regional summit organized by the Oncology Pharmacy Network\, scheduled for March 7\, 2026. \nThe conference will be held at the Crowne Plaza in Portland\, Oregon\, United States. Designed for hematology/oncology pharmacy clinicians\, including pharmacists and technicians\, the event provides a platform to network\, collaborate\, and share the latest evidence-based strategies and best practices to advance patient care within the oncology pharmacy field. \nRegister.
URL:https://oncodaily.com/event/opn-pacific-northwest-429035
LOCATION:Crowne Plaza Portland-Downtown Conv Ctr\, 1441 NE 2nd Ave\, Portland\, OR\, 97232\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/OPN-Pacific-Northwest.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260309
DTEND;VALUE=DATE:20260310
DTSTAMP:20260406T035543
CREATED:20260118T190819Z
LAST-MODIFIED:20260118T190827Z
UID:10000595-1773014400-1773100799@oncodaily.com
SUMMARY:Minimal Residual Disease in Multiple Myeloma: Future Directions and Controversies
DESCRIPTION:The webinar “Minimal Residual Disease in Multiple Myeloma: Future Directions and Controversies” is a high-level clinical session scheduled for March 9\, 2026\, at 18:00 CET. \nServing as the second installment of a specialized series by SPCC (Sharing Progress in Cancer Care)\, this activity moves beyond foundational knowledge to tackle the most debated aspects of MRD in current oncology. Led by a panel of international experts including Jesús San-Miguel\, Luciano Costa\, and Elena Zamagni\, the discussion will focus on the feasibility of MRD-driven treatment de-escalation\, the challenge of spatial heterogeneity\, and the integration of imaging with molecular techniques.
URL:https://oncodaily.com/event/minimal-residual-disease-443045
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/SPCC-4.webp
ORGANIZER;CN="Sharing Progress in Cancer Care":MAILTO:info@spcc.net
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260309
DTEND;VALUE=DATE:20260311
DTSTAMP:20260406T035543
CREATED:20260105T212607Z
LAST-MODIFIED:20260105T212616Z
UID:10000556-1773014400-1773187199@oncodaily.com
SUMMARY:Cell and Gene Therapy 2026
DESCRIPTION:The ELRIG Cell and Gene Therapy 2026 is a free-to-attend\, two-day scientific conference scheduled for March 9–10\, 2026\, in Cambridge\, UK. \nOrganized by the European Laboratory Research and Innovation Group (ELRIG)\, this event focuses on the translational journey of advanced therapies from preclinical innovation to clinical application. The technical program features four key tracks: gene therapies for neurological disorders\, advancements in sensory disorder treatments\, scaling solutions for rare diseases\, and next-generation cancer immunotherapy. \nThe oncology-specific track\, titled “Engineering the Future of Cancer Immunotherapy: Advances in T Cell Design and Function\,” explores cutting-edge developments in CAR and TCR engineering\, strategies to improve the safety and durability of T-cell therapies\, and technologies aimed at making these treatments more accessible for both hematological and solid malignancies. \nRegister.
URL:https://oncodaily.com/event/cell-and-gene-therapy-437178
LOCATION:Hinxton Hall Conference Centre\, Wellcome Genome Campus\, Hinxton\, Cambridge\, Cambridgeshire\, CB10 1RQ\, United Kingdom
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/Cell-and-Gene-Therapy-1.webp
ORGANIZER;CN="European Laboratory Research and Innovation Group (ELRIG)":MAILTO:info@elrig.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260311
DTEND;VALUE=DATE:20260313
DTSTAMP:20260406T035543
CREATED:20260110T230819Z
LAST-MODIFIED:20260110T230836Z
UID:10000565-1773187200-1773359999@oncodaily.com
SUMMARY:2026 NCODA Global Oncology and Haematology Congress
DESCRIPTION:The 2026 NCODA Global Oncology and Hematology Congress is a premier international gathering of oncology\, hematology\, and technology experts scheduled for March 11–12\, 2026\, in Dublin\, Ireland. \nOrganized by NCODA\, the congress focuses on “bridging innovation and patient-centered care” through collaborative sessions that highlight best practices in medically integrated oncology. The technical program is designed to provide actionable insights into treatment sequencing\, therapy challenge management\, and patient adherence. \nThe event serves as a critical networking hub for physicians\, pharmacists\, nurses\, and industry partners dedicated to streamlining clinical workflows and improving global patient outcomes. \nRegister.
URL:https://oncodaily.com/event/ncoda-global-oncology-439449
LOCATION:The Shelbourne\, Autograph Collection\, 27 St Stephen's Green\, Dublin\, Leinster\, D02 K224\, Ireland
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/NCODA-1.webp
ORGANIZER;CN="NCODA":MAILTO:contact@ncoda.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260311
DTEND;VALUE=DATE:20260314
DTSTAMP:20260406T035543
CREATED:20251126T122443Z
LAST-MODIFIED:20251126T122508Z
UID:10000407-1773187200-1773446399@oncodaily.com
SUMMARY:ESMO - The Christie Preceptorship on Lung Cancer 2026: Manchester
DESCRIPTION:The ESMO – The Christie Preceptorship on Lung Cancer 2026: Manchester will be held from March 11-13\, 2026\, in Manchester\, United Kingdom. \nThe application deadline is January 21\, 2026\, at 23:59 CET\, and the course is accredited for 16 ESMO-MORA category 1 points. \nThe learning objectives cover the full spectrum of thoracic oncology\, from screening and management of early-stage non-small cell lung cancer (NSCLC) to multi-modality treatment for locally advanced disease and systemic therapy for mesothelioma and small-cell lung cancer (SCLC)\, with a focus on advanced treatments like targeted agents for actionable driver mutations\, novel immunotherapies\, and palliative care. \nApply.
URL:https://oncodaily.com/event/esmo-the-christie-preceptorship416745
LOCATION:Manchester\, United Kingdom
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/ESMO-Christie.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260312
DTEND;VALUE=DATE:20260313
DTSTAMP:20260406T035543
CREATED:20251222T214739Z
LAST-MODIFIED:20251222T214750Z
UID:10000520-1773273600-1773359999@oncodaily.com
SUMMARY:The Role of Liquid Biopsy in the Characterization of Predictive Markers of Response in Patients with Lung Cancer
DESCRIPTION:“The Role of Liquid Biopsy in the Characterization of Predictive Markers of Response in Patients with Lung Cancer” is a specialized medical conference scheduled for March 12\, 2026\, in Bari\, Italy. \nThis educational event is designed specifically for healthcare professionals – including Pathologists\, Oncologists\, Biologists\, and Laboratory Technicians – to explore advanced diagnostic techniques that utilize biological fluids to identify genomic profiles and predict treatment responses without traditional tissue biopsies. \nRegister.
URL:https://oncodaily.com/event/liquid-biopsy-432811
LOCATION:Bari\, Italy
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/Liquid-Biopsy.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260312
DTEND;VALUE=DATE:20260315
DTSTAMP:20260406T035543
CREATED:20251105T200932Z
LAST-MODIFIED:20251105T200952Z
UID:10000324-1773273600-1773532799@oncodaily.com
SUMMARY:12th ImmunoTherapy of Cancer Conference (ITOC12)
DESCRIPTION:The 12th ImmunoTherapy of Cancer Conference (ITOC12) is a European meeting scheduled to take place from March 12 – 14\, 2026\, in Munich\, Germany. The conference provides a global platform focused on translational research in immuno-oncology\, serving as a forum for the discussion of early clinical translation and its unique challenges. Organized by WMA GmbH in scientific cooperation with various international groups\, including the ITOC Association\, the Tumor Centre in Munich (TZM)\, and the German Cancer Consortium (DKTK)\, the main goal is to allow those dedicated to the immunotherapy of cancer to exchange their knowledge and latest findings to advance oncology drug development and delivery.
URL:https://oncodaily.com/event/immunotherapy-403715
LOCATION:Medical Center Großhadern of Ludwig-Maximilian-University\, Marchioninistrasse 15\, Munich\, 81377\, Germany
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/11/Screenshot-2025-11-06-000822.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260312
DTEND;VALUE=DATE:20260316
DTSTAMP:20260406T035543
CREATED:20250918T121926Z
LAST-MODIFIED:20260106T085919Z
UID:10000241-1773273600-1773619199@oncodaily.com
SUMMARY:10th ESO SIOPE Masterclass in Paediatric Oncology
DESCRIPTION:The 10th ESO SIOPE Masterclass in Paediatric Oncology is scheduled on March 12-15\, 2026\, with the first block delivered online and the second block held in Barcelona\, Spain. It offers state-of-the-art plenary lectures\, interactive workshops\, tumor board simulations\, and case-based discussions with expert feedback. \nThe program is aimed at enhancing clinical management skills in childhood tumors\, leukemia\, and lymphoma\, applying the latest research findings to practice. Attendance is by application only\, with successful applicants granted free registration. The course also provides 30 ESCO credits for continuing medical education.
URL:https://oncodaily.com/event/eso-siope-345949
LOCATION:Hospital Sant Joan de Deu\, Pg. de Sant Joan de Déu\, 2\, 08950 Esplugues de Llobregat
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/09/G0-M3ipWQAAdUB-.jpeg
ORGANIZER;CN="European School of Oncology":MAILTO:eso@eso.net
END:VEVENT
END:VCALENDAR